Bullboard - Stock Discussion Forum Horizons Psychedelic Stock Index ETF HPSYF

Consumer Cyclical

PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North... see more

Add To Watchlist

GREY:HPSYF - Post Discussion

Horizons Psychedelic Stock Index ETF > $PSYK Competitor $ORIG to IPO This Quarter

View:

Post by partystocker on Nov 23, 2021 3:35pm

$PSYK Competitor $ORIG to IPO This Quarter

The more I read about Origin Therapeutics the more excited I am for them to go public. Through a portfolio including both private and public companies, it’s going to give retail investors a chance to gain exposure to companies in the psychedelic field that would normally only be accessible to venture capitalists.

Their portfolio is quite diverse ranging from businesses involved in the promotion of psychedelics to clinics and manufacturers. They also offer 0% fees unlike a lot of funds.

We can expect Origin to be traded publicly on the CSE this quarter under $ORIG.C. I recommend checking out the investor presentation to get more info about their operations.

https://originpsychedelics.com/wp-content/uploads/2021/11/Origin-Presentation-V28.pdf

104